Clinical trials
Phase 1 Dry Eye Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Not yet recruiting | 5 |
| Recruiting | 4 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laboratorios Sophia S.A de C.V. | 7 |
| Medical University of Vienna | 3 |
| Singapore National Eye Centre | 3 |
| Allergan | 2 |
| Eleven Biotherapeutics | 2 |
| Eye & ENT Hospital of Fudan University | 2 |
| Instituto de Oftalmología Fundación Conde de Valenciana | 2 |
| AbbVie | 1 |
| Aerie Pharmaceuticals | 1 |
| Alcon Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dry Eye Syndromes | 59 |
| Sjogren's Syndrome | 3 |
| Lupus Erythematosus, Systemic | 2 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
| Blepharitis | 1 |
| Dermatomyositis | 1 |
| Eye Pain | 1 |
| Graft vs Host Disease | 1 |
| Hypersensitivity | 1 |
Trials
Showing 51 to 59 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.